HealthKetamine-Based Antidepression Nasal Spray Gets FDA Thumbs Up The FDA announced on Tuesday that esketamine has been approved for people with treatment-resistant depression. The drug developed by Janssen Pharmaceuticals Inc. can offer quick relief from symptoms for patients living with the mood disorder.by Diane Samson
HealthDrug Manufacturer Points Finger At FDA Label Change Regulation As Cause Of Opioid Problemby Diane Samson
HealthState Sanctioned Vaccine Exemptions Could Force Federal Hands To Move, Says FDA Chiefby Diane Samson
HealthAmerican Lung Association Says The FDA Isn't Doing Enough To Keep E-Cigs Away From Childrenby Diane Samson